is it normal to feel hungry on tirzepatide Why Am I Still Tirzepatide​? Why Am I Still Hungry

Key Takeaways Tirzepatide (Zepbound) produces greater average weight loss than semaglutide (Wegovy) across both clinical trials and the first direct head-to-head comparison, 20.9% versus 14.9% in separate Phase 3 trials, and 20.2% versus 13.7% in the SURMOUNT-5 trial published in the New England Journal of Medicine

Understanding the risks associated with this condition is essential for developing effective strategies to combat it

These treatments fall outside NHS commissioning and NICE guidance for weight management

SCDs (sequential compression devices) are the squeezers doctors use to reduce DVT formation in the legs